Plasma cortisol in Alzheimer's disease with or without depressive symptoms

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 681-689

  Zvěřová, Martina ^a   Fišar, Zdeněk ^a   Jirák, Roman ^a   Kitzlerová, Eva ^a   Hroudová, Jana ^a   Raboch, Jiří ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alzheimer's disease; Cognitive impairment; Cortisol; Depression

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GERIATRIC DEPRESSION SCALE; HAMILTON SCALE; HUMAN; HYPERCORTISOLISM; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; DEMOGRAPHY; DEPRESSION; HUMANS; HYDROCORTISONE; LINEAR MODELS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84882705547     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889110     Document Type: Article

References (51)

1. Migliorelli R, Tesón A, Sabe L et al: Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry, 1995; 152: 37-44
2. Lyketsos CG, Olin J: Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry, 2002; 52: 243-52
3. Starkstein SE, Jorge R, Mizrahi R, Robinson RG: The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry, 2005; 162: 2086-93
4. Lyketsos CG, Carrillo MC, Ryan JM et al: Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement, 2011; 7: 532-39
5. Sierksma AS, van den Hove DL, Steinbusch HW, Prickaerts J: Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? Eur J Pharmacol, 2010; 626: 72-82
6. Ricci S, Fuso A, Ippoliti F, Businaro R: Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease. J Alzheimers Dis, 2012; 28: 11-24
7. Schmidt HD, Shelton RC, Duman RS: Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology, 2011; 36: 2375-94
8. Maes M, Fišar Z, Medina M et al: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology, 2012; 20: 127-50
9. Bao AM, Meynen G, Swaab DF: The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev, 2008; 57: 531-53
10. Gold PW, Chrousos GP: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry, 2002; 7: 254-75
11. Holsboer F: Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord, 2001; 62: 77-91
12. Otte C, Hart S, Neylan TC et al: A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology, 2005; 30: 80-91
13. Van Cauter E, Leproult R, Kupfer DJ: Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab, 1996; 81: 2468-73
14. Laughlin GA, Barrett-Connor E: Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab, 2000; 85: 3561-68
15. Halbreich U, Asnis GM, Zumoff B et al: Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res, 1984; 13: 221-29
16. Gotthardt U, Schweiger U, Fahrenberg J et al: Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol, 1995; 268: R865-73
17. O'Brien JT, Lloyd A, McKeith I et al: A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry, 2004; 161: 2081-90
18. Hinkelmann K, Moritz S, Botzenhardt J et al: Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry, 2009; 66: 879-85
19. Köhler S, Thomas AJ, Lloyd A et al: White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry, 2010; 196: 143-49
20. Hartaigh B, Loerbroks A, Thomas GN, et al: Age-dependent and-independent associations between depression, anxiety, DHEAS, and cortisol: from the MIPH Industrial Cohort Studies (MICS). Psychoneuroendocrinology, 2012; 37: 929-36
21. Oldehinkel AJ, van den Berg MD, Flentge F et al: Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res, 2001; 104: 39-47
22. Bremmer MA, Deeg DJ, Beekman AT et al: Major depression in late life is associated with both hypo-and hypercortisolemia. Biol Psychiatry, 2007; 62: 479-86
23. Rimmele U, Besedovsky L, Lange T, Born J: Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology, 2013; 38: 884-94
24. Schilling TM, Kölsch M, Larra MF et al: For whom the bell (curve) tolls: Cortisol rapidly affects memory retrieval by an inverted U-shaped dose-response relationship. Psychoneuroendocrinology, 2013; pii: S0306-4530(13)00005-X
25. Bob P, Fedor-Freybergh P, Jasova D et al: Dissociative symptoms and neuroendocrine dysregulation in depression. Med Sci Monit, 2008; 14(10): CR499-504
26. Fjell AM, Walhovd KB: Neuroimaging results impose new views on Alzheimer's disease-the role of amyloid revised. Mol Neurobiol, 2012; 45: 153-72
27. Zimny A, Bladowska J, Neska M et al: Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment. Med Sci Monit, 2013; 19: 86-94
28. Swaab DF, Bao AM, Lucassen PJ: The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev, 2005; 4: 141-94
29. Umegaki H, Ikari H, Nakahata H et al: Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study. Brain Res, 2000; 881: 241-43.
30. Weiner MF, Vobach S, Olsson K et al: Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry, 1997; 42: 1030-38
31. Comijs HC, Gerritsen L, Penninx BW et al: The association between serum cortisol and cognitive decline in older persons. Am J Geriatr Psychiatry, 2010; 18: 42-50
32. Huang CW, Lui CC, Chang WN et al: Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease. J Clin Neurosci, 2009; 16: 1283-86
33. Davis KL, Davis BM, Greenwald BS et al: Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry, 1986; 143: 300-5
34. Csernansky JG, Dong H, Fagan AM et al: Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry, 2006; 163: 2164-69
35. Schrijvers EM, Direk N, Koudstaal PJ et al: Associations of serum cortisol with cognitive function and dementia: the Rotterdam Study. J Alzheimers Dis, 2011; 25: 671-77
36. Gil-Bea FJ, Aisa B, Solomon A et al: HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. J Alzheimers Dis, 2010; 22: 829-38
37. Tanaka M, Ishii A, Yamano E et al: Effect of a human-type communication robot on cognitive function in elderly women living alone. Med Sci Monit, 2012; 18(9): CR550-57
38. Doecke JD, Laws SM, Faux NG et al: Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarker and Lifestyle Research Group: Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol, 2012; 69: 1318-25
39. Byers AL, Yaffe K: Depression and risk of developing dementia. Nat Rev Neurol, 2011; 7: 323-31
40. Tanaka M, Ishii A, Yamano E et al: Cognitive dysfunction in elderly females with depressive symptoms. Med Sci Monit, 2012; 18(12): CR706-11
41. Greenwald BS, Kramer-Ginsberg E, Marin DB et al: Dementia with coexistent major depression. Am J Psychiatry, 1989; 146: 1472-78
42. Ownby RL, Crocco E, Acevedo A et al: Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry, 2006; 63: 530-58
43. Lee HB, Lyketsos CG: Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry, 2003; 54: 353-62
44. Meynen G, Unmehopa UA, Hofman MA et al: Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder. J Neuroendocrinol, 2009; 21: 722-29
45. Yesavage JA, Brink TL, Rose TL et al: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res, 1982-1983; 17: 37-49
46. Hirschfeld RM: Screening for bipolar disorder. Am J Manag Care, 2007; 13: S164-69
47. Carroll BJ, Iranmanesh A, Keenan DM et al: Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. Acta Psychiatr Scand, 2012; 125: 478-91
48. Bélanger A, Candas B, Dupont A et al: Changes in serum concentrations of conjugated and unconjugated steroids in 40-to 80-year-old men. J Clin Endocrinol Metab, 1994; 79: 1086-90
49. Schüle C: Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol, 2007; 19: 213-26
50. Laske C, Stransky E, Fritsche A et al: Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Ab 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur Arch Psychiatry Clin Neurosci, 2009; 259: 80-85
51. Kumsta R, Entringer S, Hellhammer DH, Wüst S: Cortisol and ACTH responses to psychosocial stress are modulated by corticosteroid binding globulin levels. Psychoneuroendocrinology, 2007; 32: 1153-57